Pharmaceutical stocks are Shanghai Pharmaceutical Group Corporation, Beijing Sihuan Bio-Pharmaceutical Co.
1, Shanghai Pharmaceutical Group Co., Ltd (hereinafter referred to as the company) (HKEx stock code: 02607; SSE stock code: 601607) is a national state-controlled pharmaceutical industry group headquartered in Shanghai. The Company's main business covers the entire industry chain of pharmaceutical research and development and manufacturing, distribution and retailing.
According to the 2013 China Enterprise Confederation's ranking of the top 500 Chinese enterprises, the company's overall ranking ranks second in the national pharmaceutical industry, and is one of the few listed pharmaceutical companies in China that leads in both the pharmaceutical products and distribution markets, and is selected as a sample stock of the SSE 180 Index and CSI 300 Index, and its H-shares are selected as a constituent stock of the Hang Seng Index and the MSCI Index. MSCI).
2, Beijing Sihuan Biopharmaceutical Co., Ltd. was founded in 1988, stock code 000518, referred to as "Sihuan Biological", is China's earliest genetically engineered drugs and diagnostic reagents in the research, pilot test, production and sales, science, industry and trade as one of the integration of high-tech enterprises, and also one of the earliest genetically engineered drugs industrialization base. It is also one of the earliest industrialization bases of genetic engineering drugs in China.
3. China Pharmaceutical Group Corporation is the largest pharmaceutical and health industry group with the most complete industrial chain and the strongest comprehensive strength in China, which is directly managed by the State-owned Assets Supervision and Administration Commission of the State Council. It is mainly engaged in the distribution, retailing, research and development, and production of health-related products such as preventive treatment and diagnostic care.
It has 11 wholly-owned or holding subsidiaries and 5 listed companies, including Sinopharm, Sinopharm, Tiantan Bio, Modern Pharmaceuticals and Unanimous Pharmaceuticals, with an average annual growth rate of 33% in revenue, 44% in profit and 35% in total assets from 2003 to 2011, and an annual growth rate of more than 160 billion yuan in revenue in 2012, which is the only pharmaceutical and health industry group with more than 100 billion yuan in revenue in China. In 2012, the Group's revenue exceeded 160 billion yuan, making it the only pharmaceutical and health industry group in China with over 100 billion yuan.
4, Jiangsu Lianhuan Pharmaceutical Co., Ltd. is a manufacturing and sales of chemical raw materials, chemical pharmaceutical preparations and organic intermediates of the joint-stock pharmaceutical enterprises, March 4, 2003, approved by the China Securities Regulatory Commission, the Shanghai Stock Exchange public offering of 20 million shares of A shares, and successfully listed on March 19, the stock abbreviation: Lianhuan Pharmaceutical, stock code: 600513.
5. Wohua Pharmaceuticals formed Weifang Traditional Chinese Medicine Factory in Shandong Province in January 1959 on the basis of the traditional Chinese medicine processing department of Wanhetang Pharmacy and the tablet processing group of Shandong Province Changwei Center Pharmaceutical Material Company.
In February 2002, the company was restructured into Weifang Wohua Pharmaceutical Science and Technology Co. On January 24, 2007, the company's shares were officially listed on the Shenzhen Stock Exchange, becoming the first listed pharmaceutical company in Weifang City, and on August 8, 2008, the shares of Wohua Pharmaceuticals were successfully directed to the issuance of additional shares.
Baidu Encyclopedia-Shanghai Pharmaceutical Group Co.
Baidu Encyclopedia-Beijing Sihuan Biopharmaceutical Co.
Baidu Encyclopedia-China Pharmaceutical Group Corporation
Baidu Encyclopedia-Jiangsu Soviet Union Ring Pharmaceutical Co.